Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574340 · ClinicalTrials.gov registry record · Early Phase 1
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT00574340 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 20 participants.
The verdict
NCT00574340, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Hypoglycemia (low blood glucose level) occurs frequently in intensively treated patients with diabetes. Although hypoglycemia was thought to occur almost exclusively in T1DM, with the advent of improved metabolic control in T2DM, the incidence of hypoglycemia is rising in these patients. Therefore in this application, we will test the novel hypothesis that prior hypoglycemia will result in (cardiovascular complications) during subsequent hypoglycemia.
Interventions
- OTHER Hyperinsulinemic Hypoglycemic Clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-05 |
| Est. Completion | 2011-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574340
The ClinicalTrials.gov registry entry for NCT00574340 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperinsulinemic Hypoglycemic Clamp is the first listed.
NCT00574340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574340 about?
NCT00574340 is a clinical study titled "Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4". Hypoglycemia (low blood glucose level) occurs frequently in intensively treated patients with diabetes. Although hypoglycemia was thought to occur almost exclusively in T1DM, with the advent of improved metabolic control in T2DM, the incidence of hypoglycemia is rising in these patients. Therefore i...
What is the current status of trial NCT00574340?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2007-05. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00574340?
The interventions under investigation include: Hyperinsulinemic Hypoglycemic Clamp (OTHER).
Who is sponsoring clinical trial NCT00574340?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.